OpenAlex records 17 works, 446 citations, and an h-index of 9 for Pancheng Xie (ORCID 0000-0001-6311-6092), with strong output concentrated in 2016β2017 and a shift toward first/senior roles by 2023 (). Citations are driven by high-impact venues: an eLife paper on Tie2 and venous specification (82 citations), a Molecular Cell paper on CLOCK acetylating ASS1 for ureagenesis rhythms (81), an NAR paper on eRF1 and codon usage (73), and a Nature Communications paper decoupling PER-CK1 interaction from clock function (45) ().
Xie's most rigorously documented contribution is the Nature Communications study on PER2-CK1 docking. Using CRISPR knock-in mice (Per2 V720G/L721G), co-immunoprecipitation, RNA-seq (n=3 mice/timepoint over 24 h), ChIP-seq, and AlphaFold-guided mutagenesis, the team showed that abolishing PER-CK1 interaction decouples PER phosphorylation/stability from clock output, supporting a two-loop clock model (CK1-dependent CLOCK removal from DNA plus CK1-independent PER-CRY repression) (). The 2023 PNAS first-author paper challenges the view that PERIOD proteins form liquid-liquid phase-separated condensates, arguing for dynamic interacting microbodies at endogenous expression levels (). Collaborations with Yi Liu, Joseph Takahashi, and Kun-Liang Guan signal integration into elite circadian and metabolism networks.
The Nat Commun work was limited by single-cycle RNA-seq profiling, incompletely reported sex/sample sizes, and reliance on HEK293T overexpression for mechanistic inference (). Most publications place Xie in middle-authorship, making individual contribution difficult to isolate from lab leadership. Data availability is strong (SRA deposits PRJNA766147, PRJNA766292), supporting reproducibility. Confidence: moderate-to-high; bibliometric data is objective, but per-author causal contribution is inherently uncertain.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.